C12N 2506/30
From cancer cells
Official title: from cancer cells, e.g. reversion of tumour cells
C12N2506/30 (From cancer cells) appears on 107 US grants and 149 published applications in this corpus.
Search patents in C12N- Granted patents
- 107
- Published applications
- 149
- Assignees
- 65
- Inventors
- 194
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 4 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 4 |
| 2008 | 1 | 2 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 4 |
| 2015 | 1 | 6 |
| 2016 | 4 | 4 |
| 2017 | 1 | 11 |
| 2018 | 7 | 7 |
| 2019 | 8 | 12 |
| 2020 | 10 | 15 |
| 2021 | 23 | 27 |
| 2022 | 10 | 16 |
| 2023 | 4 | 12 |
| 2024 | 6 | 6 |
| 2025 | 9 | 7 |
| 2026 | 10 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy16 Jun 2026US 12,655,389 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy9 Jun 2026US 12,648,962 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy2 Jun 2026US 12,642,816 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy26 May 2026US 12,636,318 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy12 May 2026US 12,622,927 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272985 A1Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272986 A1Iovance Biotherapeutics, Inc.
- Methods Utilizing Single Cell Genetic Data for Cell Population Analysis and Applications Thereof17 Sep 2026US 2026/0275413 A1The Board of Trustees of the Leland Stanford Junior University
- Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy23 Oct 2025US 2025/0329428 A1Iovance Biotherapeutics, Inc.
- Pharmaceutical composition for treating or preventing malignant breast cancer2 Oct 2025US 2025/0306008 A1
Most cited
By later US patents
- Processes and products involving cell modification56US 4,528,265 A1985
- Preparation of pure cultures of post-mitotic human neurons56US 5,175,103 AThe Trustees of the University of Pennsylvania · 1992
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy55US 10,130,659 B2Iovance Biotherapeutics, Inc. · 2018
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy52US 10,363,273 B2Iovance Biotherapeutics, Inc. · 2019
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy40US 10,537,595 B2Iovance Biotherapeutics, Inc. · 2020